Secondary objective
SECONDARY
The secondary objective is to determine the effects of methylprednisolone on key CMR efficacy parameters, clinical endpoints in terms of mortality and hospitalization for HF at 3 months, peak of cardiac markers, and safety. All objectives are specified in the “